Search for: "Genentech, Inc. v. Hospira, Inc."
Results 21 - 25
of 25
Sorted by Relevance
|
Sort by Date
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
21 Feb 2018, 7:45 pm
Genentech, Inc., Case IPR2017-00739 (PTAB July 27, 2017) (Paper 16) Cultec, Inc. v. [read post]
15 Dec 2014, 7:25 am
After his earlier post on Hospira v Genentech [on which see also the IPKat earlier note here], Darren provides a catch-up summarizing the large number of comments and the debate that it has generated. [read post]
22 Dec 2014, 3:41 am
As Shalini Bengani explains in this post,TufAmerica Inc v W B Music Corp 13-cv-7847(LAK), decided by the US District Court for the Southern District of New York, is another one of those cases. [read post]
21 Oct 2014, 12:00 am
In Hospira UK Ltd v Genentech Inc[2014] EWHC 1094 (Pat), noted by the IPKat here, Birss J had to deal with inventive step of an ‘incremental’ invention, and he found the inventive concept, which related to a dosage regimen, to be obvious. [read post]
